Kenneth Hornbuckle, DVM, PhD
Associate Vice President - Pharmacoepidemiology
Eli Lilly and Company
Indiainapolis, United States
Marie Louise De Bruin, PhD (she/her/hers)
Professor
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Netherlands
Christine Hallgreen, PhD
Associate professor
Copenhagen Centre for Regulatory Science, University of Copenhagen
Copenhagen, Denmark
Presenting Author: Hong Yang, PhD – FDA/CBER/OBPV
Presenting Author: Rachael DiSantostefano (she/her/hers) – Janssen Research & Development
Presenting Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Presenting Author: Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
Presenting Author: Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Presenting Author: Marius M. Flege, MD (he/him/his) – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg